KAST vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

KAST

EmergingFintech

Stablecoin-Powered Global Neobank

Raised $80M Series A at $600M valuation (Mar 2026) led by QED Investors. 1M+ users. ~$5B annualized transaction volume. 15-20% MoM growth. Ex-Circle founder. 190+ countries.

About

KAST is a stablecoin-native neobank designed for cross-border payments and financial services in 190+ countries, founded by a former Circle executive who built stablecoin infrastructure before pivoting to consumer applications of the technology. The company raised $80 million in Series A financing at a $600 million valuation in March 2026, led by QED Investors with Left Lane Capital, Peak XV Partners, and DST Global. KAST has 1 million+ users and processes approximately $5 billion in annualized transaction volume, growing 15-20% month-over-month.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.